Cetta, F, Feldt, RH, O’Leary, PW, et al. Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol
1996; 28: 480–486.
Gentles, TL, Mayer, JE Jr, Gauvreau, K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg
1997; 114: 376–391.
Gewillig, M, Goldberg, DJ. Failure of Fontan circulation. Heart Fail Clin
2014; 10: 105–116.
Baek, JS, Bae, EJ, Ko, JS, et al. Late hepatic complications after Fontan operation: non-invasive markers of hepatic fibrosis and risk factors. Heart
2010; 96: 1750–1755.
Mori, M, Aquirre, AJ, Elder, RW, et al. Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol
2014; 35: 569–579.
Rychik, J, Goldberg, D, Rand, E, et al. End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis. Cardiol Young
2013; 23: 831–840.
Avitabile, CM, Leonard, MB, Zemel, BS, et al. Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation. Heart
2014; 100: 1702–1707.
Bulut, OP, Romero, R, Mahle, WT, et al. Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr
2013; 163: 201–206.
Giardini, A, Balducci, A, Specchia, S, Gargiulo, G, Bonvicini, M, Picchio, FM. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J
2008; 29: 1681–1687.
Thacker, D, Patel, A, Dodds, K, Goldberg, DJ, Semeao, E, Rychik, J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg
2010; 89: 837–842.
Chin, AJ, Stephens, P, Goldmuntz, E, Leonard, MB. Serum alkaline phosphatase reflects post-Fontan hemodynamics in children. Pediatr Cardiol
2009; 30: 138–145.
Goldberg, DJ, Dodds, K, Avitabile, CM, et al. Children with protein-losing enteropathy after the Fontan operation are at risk for abnormal bone mineral density. Pediatr Cardiol
2012; 33: 1264–1268.
Kim, SJ, Park, IS, Song, JY, Lee, JY, Shim, WS. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation. Ann Thorac Surg
2004; 77: 1456–1457.
Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab
2011; 96: 1911–1930.
Misra, M, Pacaud, D, Petryk, A, Collett-Solberg, PF, Kappy, M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics
2008; 122: 398–417.
Norman, PE, Powell, JT. Vitamin D and cardiovascular diseases. Circ Res
2014; 114: 379–393.
Beigelman, A, Zeiger, RS, Mauger, D, et al. The associations between vitamin D status and rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. J Allergy Clin Immunol
2014; 133: 1489–1492.
Huibers, MH, Visser, DH, Deckers, MM, van Schoor, NM, van Furth, AM, Wolf, BH. Vitamin D deficiency among native Dutch and first- and second-generation non-western immigrants. Eur J Pediatr
2014; 173: 583–588.
Kelly, A, Brooks, LJ, Dougherty, S, Carlow, DC, Zemel, BS. A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child
2011; 96: 447–452.
Lee, JH, O’Keefe, JH, Bell, D, Hensrud, DD, Holick, MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
J Am Coll Cardiol
2008; 52: 1949–1956.
McNally, JD, Menon, K, Chakraborty, P, et al. The association of vitamin D status with pediatric critical illness. Pediatrics
2012; 130: 429–436.
McNally, JD, Sampson, M, Matheson, LA, Hutton, B, Little, J. Vitamin D receptor (VDR) polymorphisms and severe RSV bronchiolitis: a systematic review and meta-analysis. Pediatr Pulmonol
2014; 49: 790–799.
Schaffrath Rosario, A, Schienkiewitz, A, Neuhauser, H. German height references for children aged 0 to under 18 years compared to WHO and CDC growth charts. Ann Human Biol
2011; 38: 121–130.
Schaffrath Rosario, A, Kurth, BM, Stolzenberg, H, Ellert, U, Neuhauser, H. Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003-2006). Eur J Clin Nutr
2010; 64: 341–349.
Bergmann, KE, Mensink, GB. Anthropometric data and obesity. Gesundheitswesen
1999; 61: S115–S120.
John, SA, Johnson, JA, Khan, M, Driscoll, DJ, Warnes, CA, Cetta, F. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol
2014; 64: 54–62.
Uthamalingam, S, Patvardhan, EA, Subramanian, S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol
2011; 107: 433–438.
Gruppen, MP, Davin, JC, Oosterveld, MJ, et al. Prevention of steroid-induced low bone mineral density in children with renal diseases: a systematic review. Nephrol Dial Transplant
2013; 28: 2099–2106.
Liu, LC, Voors, AA, van Veldhuisen, DJ, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail
2011; 13: 619–625.
Anderson, JL, Vanwoerkom, RC, Horne, BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent factors?
Am Heart J
2011; 162: 331–339.
Gandhi, S, Myers, RB. Can parathyroid hormone be used as a biomarker for heart failure?
Heart Fail Rev
2013; 18: 465–473.
Inai, K, Nakanishi, T, Nakazawa, M. Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation. Am Heart J
2005; 150: 588–594.
Saiki, H, Kuwata, S, Kurishima, C, et al. Aldosterone-cortisol imbalance immediately after Fontan operation with implications for abnormal fluid homeostasis. Am J Cardiol
2014; 114: 1578–1583.
Tomaschitz, A, Ritz, E, Pieske, B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res
2012; 94: 10–19.
Avgeri, M, Papadopoulou, A, Platokouki, H, et al. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol
2008; 30: 592–597.
Bendaly, EA, DiMeglio, LA, Fadel, WF, Hurwitz, RA. Bone density in children with single ventricle physiology. Pediatr Cardiol
2015; 36: 779–785.
Pappa, H, Thayu, M, Sylvester, F, Leonard, M, Zemel, B, Gordon, C. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr
2011; 53: 11–25.
Brown, JM, Vaidya, A. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Curr Opin Endocrinol Diabetes Obes
2014; 21: 193–201.
Sharma, R, Bolger, AP, Li, W, et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol
2003; 92: 188–193.
Ostrow, AM, Freeze, H, Rychik, J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg
2006; 82: 695–700.
Bode, L, Salvestrini, C, Park, PW, et al. Heparan sulphate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest
2008; 118: 229–238.
Chueng, YF, Tsang, HY, Kwok, JS. Immunologic profile of patients with protein-losing enteropathy complicating congenital heart disease. Pediatr Cardiol
2002; 23: 587–593.